• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Screening of influenza mutations using base-specific cleavage and MALDI mass spectrometry

tetano

Editor, Senior Moderator
Clin Chim Acta. 2012 Oct 15. pii: S0009-8981(12)00480-9. doi: 10.1016/j.cca.2012.10.013. [Epub ahead of print]
Screening of influenza mutations using base-specific cleavage and MALDI mass spectrometry.
Gao X, Sugrue RJ, Tan BH, Tang K.
Source

Division of Chemical Biology and Biotechnology, School of Biological Sciences, Nanyang Technological University, Singapore.
Abstract
BACKGROUND:

The Hemagglutinin (HA) and neuraminidase (NA) genes encode surface glycoproteins of influenza virus. These two proteins are involved in pathogenicity and are the primary targets of the immune system. Mutations in the HA and NA genes can result in antigenic drift in an influenza viral strain. A comparative sequencing method using MALDI MS combined with base-specific cleavage has been applied for the surveillance of these viral mutations. This approach shows advantages in high throughput and efficiency than the traditional direct sequencing methods in targeted sequence analysis.
METHODS:

Base-specific cleavage assay with RNAse A was combined with MALDI-MS for the analysis of the HA and NA genes of 2 influenza viral strains. The mass peak patterns from the spectra were compared with the in silico digest result of reference gene sequences from the database to achieve comparative sequencing and screening of novel mutations.
RESULTS:

The HA and NA genes of two influenza lab strains were comparatively sequenced using the base-specific cleavage & MALDI-MS approach. Mutations could be exactly identified if more than one observation (mass peak changes) were detected in the spectrum. Mutations with only one observation could be located in a small area for further validation.
CONCLUSIONS:

We showed a proof of principle that base-specific combined with MALDI-MS comparative sequencing approach can be utilized for targeted sequence analysis and potentially rapid and cost effective screening of emerging viral mutations.

Copyright ? 2012. Published by Elsevier B.V.

PMID:
23078853
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23078853
 
Back
Top Bottom